MDSpire - Takeaway
Clinical Guidelines

Mapping Carbon Hotspots in Pharma Supply Chains

New framework combining LCA and network analysis reveals hidden leverage points for decarbonization in complex drug supply networks

  • March 30, 2026

  • 2 min

Share

  • 1

    Emission reduction in pharma supply chains is network-dependent.

  • 2

    Logistics hubs can greatly influence carbon footprints.

  • 3

    Life Cycle Assessment (LCA) and Social Network Analysis (SNA) used in research.

  • 4

    Responsibility Contribution Index (RCI) captures emissions and influence.

  • 5

    Targeting strategically important nodes can lead to significant carbon reductions.

Original Source(s)

Mapping Carbon Hotspots in Pharma Supply Chains

  • March 30, 2026

Related Content

GlycoRNA Comes into Focus with Mass Spectrometry Blueprint

New review maps analytical workflows to decode a surprising class of sugar-coated RNA

  • March 30, 2026

  • 2 min
Root Canal Treatment Linked to Metabolic Improvements

Longitudinal NMR metabolomics study suggests clearing apical periodontitis may reduce systemic inflammation and improve glucose and lipid profiles

  • March 30, 2026

  • 3 min
FDA Approval Advances Basal Insulin

Weekly dosing reduces injection frequency vs daily regimens, with phase 3 data supporting efficacy and class-consistent safety.